SK287644B6 - Kryštalický N-(trans)-4-izopropylcyklohexylkarbonyl)-D- fenylalanín vo forme C a spôsob jeho prípravy - Google Patents

Kryštalický N-(trans)-4-izopropylcyklohexylkarbonyl)-D- fenylalanín vo forme C a spôsob jeho prípravy Download PDF

Info

Publication number
SK287644B6
SK287644B6 SK5005-2004A SK50052004A SK287644B6 SK 287644 B6 SK287644 B6 SK 287644B6 SK 50052004 A SK50052004 A SK 50052004A SK 287644 B6 SK287644 B6 SK 287644B6
Authority
SK
Slovakia
Prior art keywords
isopropylcyclohexylcarbonyl
phenylalanine
methyl ester
trans
phenylalanine methyl
Prior art date
Application number
SK5005-2004A
Other languages
English (en)
Slovak (sk)
Other versions
SK50052004A3 (sk
Inventor
Shanmughasamy Rajamahendra
Chandrashekar Aswathanarayanappa
Tom Thomas Puthiaparampil
Madhavan Sridharan
Sambasivam Ganesh
Original Assignee
Biocon Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Limited filed Critical Biocon Limited
Publication of SK50052004A3 publication Critical patent/SK50052004A3/sk
Publication of SK287644B6 publication Critical patent/SK287644B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK5005-2004A 2002-04-29 2002-04-29 Kryštalický N-(trans)-4-izopropylcyklohexylkarbonyl)-D- fenylalanín vo forme C a spôsob jeho prípravy SK287644B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000114 WO2003093222A1 (en) 2002-04-29 2002-04-29 Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine

Publications (2)

Publication Number Publication Date
SK50052004A3 SK50052004A3 (sk) 2005-03-04
SK287644B6 true SK287644B6 (sk) 2011-05-06

Family

ID=29287383

Family Applications (1)

Application Number Title Priority Date Filing Date
SK5005-2004A SK287644B6 (sk) 2002-04-29 2002-04-29 Kryštalický N-(trans)-4-izopropylcyklohexylkarbonyl)-D- fenylalanín vo forme C a spôsob jeho prípravy

Country Status (13)

Country Link
US (1) US7314955B2 (enExample)
EP (1) EP1499586A4 (enExample)
JP (1) JP4137053B2 (enExample)
KR (1) KR20040111490A (enExample)
AU (1) AU2002304281A1 (enExample)
CA (1) CA2481322A1 (enExample)
CZ (1) CZ2004997A3 (enExample)
HR (1) HRP20040920A2 (enExample)
HU (1) HUP0500259A2 (enExample)
IL (1) IL164327A0 (enExample)
MX (1) MXNL04000084A (enExample)
SK (1) SK287644B6 (enExample)
WO (1) WO2003093222A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2004997A3 (cs) 2002-04-29 2005-01-12 Biocon Limited Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu
US6861553B2 (en) 2002-07-03 2005-03-01 Teva Pharmaceuticals Industries Ltd. Process for preparing nateglinide and intermediates thereof
US7148376B2 (en) 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7358390B2 (en) 2002-07-18 2008-04-15 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7420084B2 (en) 2002-07-18 2008-09-02 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7534913B2 (en) 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
WO2004020396A1 (en) * 2002-08-28 2004-03-11 Dr. Reddy's Laboratories Limited Crystalline form of nateglinide and process for preparation thereof
WO2004074330A1 (ja) * 2003-02-18 2004-09-02 Konishi Co., Ltd. 硬化性樹脂、その製造方法及び硬化性樹脂組成物
HU227073B1 (hu) * 2003-07-10 2010-06-28 Richter Gedeon Nyrt Eljárás királisan tiszta N-(transz-4-izopropil-ciklohexilkarbonil)-D-fenil-alanin (nateglinid) és kristálymódosulatainak elõállítására, valamint a G-kristálymódosulata
US20070231393A1 (en) * 2004-05-19 2007-10-04 University Of South Carolina System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles
GB0413084D0 (en) * 2004-06-11 2004-07-14 Cipla Ltd Process
US20100004334A1 (en) * 2008-07-01 2010-01-07 Mead Johnson Nutrition Company Nutritional Compositions Containing Punicalagins
US11390830B2 (en) 2018-10-05 2022-07-19 The Chemours Company Fc, Llc Compositions comprising 1,2-dichloro-1,2-difluoroethylene for use in cleaning and solvent applications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
US4814684A (en) * 1987-09-30 1989-03-21 Trw Inc. Apparatus for extending the Vout/Vin ratio of a DC-to-DC converter
EP0526171B1 (en) * 1991-07-30 1997-03-05 Ajinomoto Co., Inc. Crystals of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine and methods for preparing them
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
CZ2004997A3 (cs) 2002-04-29 2005-01-12 Biocon Limited Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu

Also Published As

Publication number Publication date
SK50052004A3 (sk) 2005-03-04
WO2003093222A1 (en) 2003-11-13
EP1499586A1 (en) 2005-01-26
KR20040111490A (ko) 2004-12-31
US20050165108A1 (en) 2005-07-28
HUP0500259A2 (hu) 2005-06-28
IL164327A0 (en) 2005-12-18
MXNL04000084A (es) 2006-02-28
EP1499586A4 (en) 2006-01-18
JP2005523933A (ja) 2005-08-11
JP4137053B2 (ja) 2008-08-20
HRP20040920A2 (en) 2005-02-28
CZ2004997A3 (cs) 2005-01-12
AU2002304281A1 (en) 2003-11-17
CA2481322A1 (en) 2003-11-13
US7314955B2 (en) 2008-01-01

Similar Documents

Publication Publication Date Title
US7893279B2 (en) Cyclohexanecarboxylic acid compound
FI64159B (fi) Foerfarande foer framstaellning av oralt effektiva antiallergiska 11-oxo-11-h-pyrido(2,1-b)-kinazoliner
SK287644B6 (sk) Kryštalický N-(trans)-4-izopropylcyklohexylkarbonyl)-D- fenylalanín vo forme C a spôsob jeho prípravy
HU219343B (en) Process for producing acylated arylalkylamine derivatives and pharmaceutical compositiions comprising them
JP2008542291A (ja) 網膜疾患を処置するための組成物および方法
CN102030700B (zh) 苯甲酰胺基羧酸类化合物及其制法和药物用途
WO2011145669A1 (ja) アミド誘導体
AU2024246814A1 (en) Cyclic amine derivative, and composition and use thereof
KR20110017452A (ko) 무스칼린 수용체 길항제로서 활성인 신규한 화합물
SA519402283B1 (ar) مركبات أميد واستخدامها
JP2005530809A (ja) フェニルシクロヘキシルプロパノールアミン誘導体、その製造法、およびその治療的適用
JPS6253966A (ja) 新規ピリジン誘導体
WO2006042103A2 (en) Reversible inhibitors of cathepsin b
JPH09221479A (ja) アミノベンゼンスルホン酸誘導体一水和物及びその製造方法
CN103232398B (zh) 一种瑞舒伐他汀氨基酸盐及其制备方法和应用
US4125625A (en) Troponyl-oxamic acid derivatives
KR20150042275A (ko) 3-포르밀리파마이신 sv 및 3-포르밀리파마이신 s의 3-(4-신나밀-l-피페라지닐) 아미노 유도체를 함유하는 제약 제제 및 그의 제조 방법
RU2324676C2 (ru) Кристаллический n-(транс-4-изопропилциклогексилкарбонил)-d-фенилаланин формы с для лечения сахарного диабета типа 2 и способ его получения
CN103012319B (zh) 瑞格列奈中间体的合成工艺改进
SU1456012A3 (ru) Способ получени N-(1-циклогексенилметил-2-пирролидинилметил)-8-этилсульфонил-1,5-бензодиоксепан-6-карбоксамида или его хлоргидрата
CN103254192B (zh) 黄嘌呤类化合物、其盐、中间体、制备方法及应用
KR101257272B1 (ko) 탈보호화 반응을 이용한 고혈압 치료용 비페닐테트라졸 화합물의 제조방법
CN120098058A (zh) 三氮唑并环类化合物及其制法、药物组合物和应用
CN118047791A (zh) 一种含氨基吡啶结构的urat1抑制剂及其制备方法与应用
CN110003117A (zh) 一种含三氟甲基嘧啶的阿魏酸酰胺衍生物及其制备和用途

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20130429